LIVTENCITY

Identification of Livtencity

No description

Google image searchProduct monograph

Active ingredient

maribavir, 200 MG

DIN: 02530740

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: TAKEDA CANADA INC

Date: 25-OCT-2022

ATC:

• J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
• J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
• J05AX — Other antivirals (ATC, ATC/DDD)
• J05AX10 — MARIBAVIR (ATC/DDD)

Reference brand drug: Livtencity

External Links for Livtencity

Search on Google

• Livtencity side effects
• Livtencity dosage
• maribavir side effects
• maribavir dosage

Takeda Canada Inc

Go to Takeda website to see drug product details. Sometimes you can find livtencity photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.